Dr. Diamond's Metacine
EyeLift: Driving DTC Revenue For A New Product Launch
Product Launch + Paid Social + Organic Social
OGAKI partnered with Dr. Diamond's Metacine to launch a new eye product, EyeLift, launching the brand’s first paid TikTok campaigns and creating bolder, social-first creative formats - cutting acquisition costs nearly in half while setting new performance benchmark for the brand.
BY
THE NUMBERS
48%
Below Target CAC
2.81x
Campaign ROAS
240%
Increase in Shares
130%
Increase in Engagement
THE CHALLENGE
Dr. Diamond’s Metacine has been making significant traction in the space through the strong reputation of its founder, thoughtful, design-forward branding, and a rigorous, results-first approach to skincare. But EyeLift represented a new territory: the brand’s first foray into the eye space, and its most ambitious DTC launch to date.
At $225, EyeLift required consumers to make a significant commitment to a brand they were still getting to know, in a category the brand had never played in before. In order to make immediate traction, trust had to be built from the first impression, clearly articulating benefits and credibility quickly enough to justify price and move consumers to purchase.
DR. DIAMOND'S METACINE EYELIFT LAUNCH
THE SOLUTION
We expanded the brand's presence on TikTok and revamped the creative approach on Instagram to capture immediate attention and trust.
Launched the brand's first-ever TikTok paid campaigns, building a channel strategy from the ground up
Introduced new UGC-style video formats to make the brand feel relatable, human, and platform-native
Developed BTS founder content to reinforce scientific credibility in a format that felt native to the feed
Created new graphic design layouts for Instagram, modernizing the brand's visual language without losing its clinical authority
Iterated on hooks and formats in real time, scaling what converted and cutting what didn't to drive acquisition efficiency throughout the campaign
THE RESULTS
The Eyelift campaign achieved 2.81x ROAS while reducing customer acquisition costs 48% below target CAC - nearly doubling acquisition efficiency and creating the unit economics to support scalable DTC growth without increasing spend.
The creative changes showcased measurable results organically as well. Campaign content drove 240% higher shares and 130% higher engagement compared to the brand's prior averages. For a brand still building awareness in a new category, EyeLift is an example of how the right creative on the right channels converts.
DR. DIAMOND'S METACINE EYELIFT LAUNCH
HIGHLIGHTS
48%
Below Target CAC
2.81x
Campaign ROAS
240%
Increase in Shares
130%
Increase in Engagement
MORE CASE STUDIES
